What Is Troubling The Biotech Industry? – ValueWalk Premium

What Is Troubling The Biotech Industry?

What Is Troubling The Biotech Industry? by Isaac Sprecher

The past several months have been especially difficult for the biotech industry. In mid-July Celgene purchased Receptos for ~8 billion dollars and the industry looked as if this bull market would go on forever. However on Friday, July 24, 2015 Biogen reported a lackluster quarter and sparked a downward spiral. Since then, the biotech industry has plunged (IBB ~33%, XBI ~43%). In January alone many small to mid cap bios were down almost 50% or more. Many additional factors have contributed to this crash; in August . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Saved Articles